Treatment with omalizumab normalizes the number of myeloid dendritic cells during the grass pollen season

J Allergy Clin Immunol. 2003 Feb;111(2):428-30. doi: 10.1067/mai.2003.56.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Child
  • Child, Preschool
  • Dendritic Cells / immunology*
  • Double-Blind Method
  • Female
  • Humans
  • Male
  • Omalizumab
  • Rhinitis, Allergic, Seasonal / immunology*
  • Rhinitis, Allergic, Seasonal / therapy*

Substances

  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Omalizumab